Novoprotein is a leading contract research biotech company dedicated solely to recombinant protein service. Novoprotein possesses advanced technology and extensive experience in the field and offers a comprehensive service portfolio, from protein expression, antibody production, protein modification, and protein crystallization. Novoprotein has accomplished over 1000 contract projects with an 85% success rate, and has developed a catalog of more than 800 enzymes and cytokines since its inception in 2004. The capacity of the four well-established protein expression systems: E.coli, yeast, baculovirus/insect cell and mammalian cell systems, have reached gram scale. At Novoprotein, the stringent QC standard ensures the highest product quality. The strict confidentiality protocol protects the privacy of our clients. Our long term clients come from all over the world, including major pharmaceutical companies and world class research institutes.
